Abstract / Description of output
We read with interest the article by Steiner et al,1 that claims that administration of fuzapladib is safe and effective in reducing 2 clinical scores in dogs with acute pancreatitis (AP). We commend Steiner et al for their efforts in addressing a critical need in veterinary medicine. This letter, however, raises significant concerns regarding the methodology and interpretation of the study results.
Original language | English |
---|---|
Pages (from-to) | 1282-1284 |
Number of pages | 3 |
Journal | Journal of Veterinary Internal Medicine |
Volume | 38 |
Issue number | 3 |
Early online date | 5 Mar 2024 |
DOIs | |
Publication status | E-pub ahead of print - 5 Mar 2024 |
Keywords / Materials (for Non-textual outputs)
- Animals
- Dog Diseases/diagnosis
- Dogs
- Pancreatitis/veterinary
- Randomized Controlled Trials as Topic